» Articles » PMID: 38756418

NET-targeted Nanoparticles for Antithrombotic Therapy in Pregnancy

Overview
Journal iScience
Publisher Cell Press
Date 2024 May 17
PMID 38756418
Authors
Affiliations
Soon will be listed here.
Abstract

Pulmonary embolism caused by deep vein thrombosis (DVT) is a major contributor to maternal morbidity and mortality. There is still an unmet need for safe and effective treatment options for DVT during pregnancy. Recent research has shown that neutrophil extracellular trap (NET) formation plays a very vital role in thrombosis. We created nanoparticles surface-modified by neutrophil elastase (NE)-binding peptide that can target activated neutrophils specifically and . Prussian blue nanoparticles (PB NPs) designed in the core scavenges abnormally elevated reactive oxygen species (ROS) in the vascular microenvironment and acts as a photothermal agent to mediate photothermal therapy (PTT) to damage fibrin network structure. Based on the data we have included, this noninvasive therapeutic approach is considered safe for both mothers and the fetus. Furthermore, our findings indicate that this therapeutic approach has a significant alleviation effect on intrauterine growth restriction caused by maternal thrombosis.

Citing Articles

Physicochemical Design of Nanoparticles to Interface with and Degrade Neutrophil Extracellular Traps.

Raghavan P, Perez C, Sorrentino T, Kading J, Finbloom J, Desai T ACS Appl Mater Interfaces. 2025; 17(6):8862-8874.

PMID: 39884672 PMC: 11826501. DOI: 10.1021/acsami.4c17324.


Application of Nanomaterials Targeting Immune Cells in the Treatment of Chronic Inflammation.

Ci Z, Wang H, Luo J, Wei C, Chen J, Wang D Int J Nanomedicine. 2024; 19:13925-13946.

PMID: 39735324 PMC: 11682674. DOI: 10.2147/IJN.S497590.

References
1.
Tran H, Gibbs H, Merriman E, Curnow J, Young L, Bennett A . New guidelines from the Thrombosis and Haemostasis Society of Australia and New Zealand for the diagnosis and management of venous thromboembolism. Med J Aust. 2019; 210(5):227-235. DOI: 10.5694/mja2.50004. View

2.
Kertschanska S, Stulcova B, Kaufmann P, STULC J . Distensible transtrophoblastic channels in the rat placenta. Placenta. 2000; 21(7):670-7. DOI: 10.1053/plac.2000.0558. View

3.
Dhayalan M, Wang W, Riyaz S, Dinesh R, Shanmugam J, Irudayaraj S . Advances in functional lipid nanoparticles: from drug delivery platforms to clinical applications. 3 Biotech. 2024; 14(2):57. PMC: 10825110. DOI: 10.1007/s13205-023-03901-8. View

4.
Irvin-Choy N, Nelson K, Dang M, Gleghorn J, Day E . Gold nanoparticle biodistribution in pregnant mice following intravenous administration varies with gestational age. Nanomedicine. 2021; 36:102412. PMC: 8641294. DOI: 10.1016/j.nano.2021.102412. View

5.
James A, Jamison M, Brancazio L, Myers E . Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol. 2006; 194(5):1311-5. DOI: 10.1016/j.ajog.2005.11.008. View